SLC5A2 and heart failure: Now that evidence is available for angiotensin receptor/neprilysin inhibitors and sodium glucose cotransporter-2 inhibitors (SGLT-2 inhibitors), reports of quadruple medical therapy (also called the Four Pillars [2] or Fantastic Four) have been increasing [3], and multidrug therapy for heart failure has become essential and standard.